• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Ann Rheum Dis. Jan 1992; 51(1): 23–28.
PMCID: PMC1004612

HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.

Abstract

The distribution of HLA-D region antigens was studied in three groups (I, IIa, and IIb) of patients with rheumatoid arthritis (RA): group I comprised 43 patients with mild, non-progressive RA, controlled by non-steroidal anti-inflammatory drugs without progression or erosions; group II comprised 94 patients with severe disease, who had earlier been treated with non-steroidal anti-inflammatory drugs and all had incomplete response requiring treatment with gold (sodium aurothiomalate). Of these, 46 patients (group IIa) responded to gold and the disease was well controlled, and the remaining 48 patients (group IIb) did not respond to gold and developed gold induced toxic reactions, including thrombocytopenia or proteinuria, or both. HLA-D region antigens were defined by serological and molecular (Southern blot analysis and oligonucleotide typing) techniques. The results show that DR4 was significantly increased in all three groups of patients. The prevalence of DR1, or DR1 in DR4 negative patients, and DR3 and DR4 associated DQw7 specificities, however, showed differences in these three groups of patients. The prevalence of DR1 and of DR1 in DR4 negative patients was increased only in patients with mild (group I) RA, but not in patients with severe (groups IIa and IIb) disease. On the other hand, the prevalence of DR4 associated DQw7 was significantly increased in patients with severe disease, but not in patients with mild RA. In addition, DR3 was significantly increased only in patients with severe disease who developed gold induced toxic reactions (group IIb). These data suggest that the HLA-D region genes which cause susceptibility to mild RA may be different from those causing susceptibility to severe RA. The results suggest that both DR and DQ (A, B) genes may be important in conferring susceptibility to RA: DR in mild disease and DQ in severe RA.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Benavides G, Silva B, Cervantes A, Katona G, Alvares V. HLA-DR4 and rheumatoid arthritis in Mexican mestizos. Arthritis Rheum. 1984 Nov;27(11):1317–1318. [PubMed]
  • Papasteriades CA, Kappou ID, Skopouli FN, Barla MN, Fostiropoulos GA, Moutsopoulos HM. Lack of HLA-antigen association in Greek rheumatoid arthritis patients. Rheumatol Int. 1985;5(5):201–203. [PubMed]
  • Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis. 1982 Aug;41(4):403–404. [PMC free article] [PubMed]
  • Stastny P, Ball EJ, Khan MA, Olsen NJ, Pincus T, Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol. 1988;27 (Suppl 2):132–138. [PubMed]
  • Panayi GS, Wooley P, Batchelor JR. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. [PMC free article] [PubMed]
  • Legrand L, Lathrop GM, Marcelli-Barge A, Dryll A, Bardin T, Debeyre N, Poirier JC, Schmid M, Ryckewaert A, Dausset J. HLA-DR genotype risks in seropositive rheumatoid arthritis. Am J Hum Genet. 1984 May;36(3):690–699. [PMC free article] [PubMed]
  • Brautbar C, Naparstek Y, Yaron M, Amar A, Ehrenfeld M, Eliakim M, Bentwich Z, Cohen T, Korman SH, Albert ED. Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens. 1986 Jul;28(1):8–14. [PubMed]
  • Nepom GT, Seyfried CE, Holbeck SL, Wilske KR, Nepom BS. Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis. Lancet. 1986 Nov 1;2(8514):1002–1005. [PubMed]
  • Ohta N, Nishimura YK, Tanimoto K, Horiuchi Y, Abe C, Shiokawa Y, Abe T, Katagiri M, Yoshiki T, Sasazuki T. Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol. 1982 Oct;5(2):123–132. [PubMed]
  • Singal DP, D'Souza M, Reid B, Bensen WG, Kassam YB, Adachi JD. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet. 1987 Nov 14;2(8568):1118–1120. [PubMed]
  • Singal DP, Bensen WG, Kassam YB. HLA-DQ polymorphism in rheumatoid arthritis. Lancet. 1988 Mar 5;1(8584):529–529. [PubMed]
  • Stephens HA, Sakkas LI, Vaughan RW, Teitsson I, Welsh KI, Panayi GS. HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis. Immunogenetics. 1989;30(2):119–122. [PubMed]
  • Lanchbury JS, Sakkas LI, Marsh SG, Bodmer JG, Welsh KI, Panayi GS. HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis. Hum Immunol. 1989 Sep;26(1):59–71. [PubMed]
  • Sansom DM, Bidwell JL, Maddison PJ, Campion G, Klouda PT, Bradley BA. HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol. 1987 Aug;19(4):269–278. [PubMed]
  • Wallin J, Carlsson B, Ström H, Möller E. A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum. 1988 Jan;31(1):72–79. [PubMed]
  • Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10049–10053. [PMC free article] [PubMed]
  • Morel PA, Horn GT, Budd RC, Erlich HA, Fathman CG. Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. Hum Immunol. 1990 Feb;27(2):90–99. [PubMed]
  • Perdriger A, Fauchet R, Chales G, Semana G, Quillivic F, Lore P, Meadeb J, Pawlotsky Y. RFLP study of the DR4-DQw3 haplotype in rheumatoid arthritis. Tissue Antigens. 1990 Apr;35(4):187–188. [PubMed]
  • Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. [PubMed]
  • Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
  • Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, Gyllensten U, Erlich HA. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A. 1988 May;85(10):3504–3508. [PMC free article] [PubMed]
  • Kenter MJ, Anholts JD, Schreuder GM, van Eggermond MC, Ghyselen GM, van Rood JJ, Giphart MJ. Unambiguous typing for HLA-DQ TA10 and 2B3 specificities using specific oligonucleotide probes. Hum Immunol. 1989 Jan;24(1):65–73. [PubMed]
  • Gregersen PK, Shen M, Song QL, Merryman P, Degar S, Seki T, Maccari J, Goldberg D, Murphy H, Schwenzer J, et al. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2642–2646. [PMC free article] [PubMed]
  • Hiraiwa A, Seyfried CE, Nepom GT, Milner EC. Sequence analysis of HLA class II domains: characterization of the DQw3 family of DQB genes. Immunogenetics. 1989;29(3):186–190. [PubMed]
  • WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. [PubMed]
  • Singal DP, Butler L, Lamontagne L. Identification of two subtypes of HLA-DR2 by Southern blot analysis. Tissue Antigens. 1986 Jul;28(1):29–40. [PubMed]
  • Singal DP, Green D, Reid B, D'Souza M. Polymorphism of three HLA-DR3-bearing major histocompatibility complex extended haplotypes. Immunogenetics. 1989;29(4):277–280. [PubMed]
  • Singal DP, Green D, D'Souza M, Reid B. Polymorphism of three HLA-DR7 bearing major histocompatibility complex extended haplotypes. Mol Immunol. 1989 Aug;26(8):705–710. [PubMed]
  • Singal DP, Reid B, Green D, D'Souza M, Bensen WG, Buchanan WW. Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria. Ann Rheum Dis. 1990 Aug;49(8):582–586. [PMC free article] [PubMed]
  • Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med. 1980 Aug 7;303(6):300–302. [PubMed]
  • Coblyn JS, Weinblatt M, Holdsworth D, Glass D. Gold-induced thrombocytopenia. A clinical and immunogenetic study of twenty-three patients. Ann Intern Med. 1981 Aug;95(2):178–181. [PubMed]
  • Bardin T, Dryll A, Debeyre N, Ryckewaert A, Legrand L, Marcelli A, Dausset J. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis. 1982 Dec;41(6):599–601. [PMC free article] [PubMed]
  • Gran JT, Husby G, Thorsby E. HLA DR antigens and gold toxicity. Ann Rheum Dis. 1983 Feb;42(1):63–66. [PMC free article] [PubMed]
  • van Riel PL, Reekers P, van de Putte LB, Gribnau FW. Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens. 1983 Sep;22(3):194–199. [PubMed]
  • Hakala M, van Assendelft AH, Ilonen J, Jalava S, Tiilikainen A. Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis. 1986 Mar;45(3):177–182. [PMC free article] [PubMed]
  • Adachi JD, Bensen WG, Kassam Y, Powers PJ, Bianchi FA, Cividino A, Kean WF, Rooney PJ, Craig GL, Buchanan WW, et al. Gold induced thrombocytopenia: 12 cases and a review of the literature. Semin Arthritis Rheum. 1987 May;16(4):287–293. [PubMed]
  • Majoos FL, Klemp P, Meyers OL, Briggs B. Gold therapy in rheumatoid arthritis. S Afr Med J. 1981 Jun 27;59(27):971–974. [PubMed]
  • Dequeker J, Van Wanghe P, Verdickt W. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis. J Rheumatol. 1984 Jun;11(3):282–286. [PubMed]
  • Nepom GT, Hansen JA, Nepom BS. The molecular basis for HLA class II associations with rheumatoid arthritis. J Clin Immunol. 1987 Jan;7(1):1–7. [PubMed]
  • McCusker CT, Singal DP. Molecular relationships between the class II HLA antigens and susceptibility to rheumatoid arthritis. J Rheumatol. 1988 Jul;15(7):1050–1053. [PubMed]
  • Singal DP, Reid B, Green D, Bensen WG, D'Souza M. DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis. Ann Rheum Dis. 1990 Mar;49(3):143–146. [PMC free article] [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...